ATYPICAL PARKINSON DISEASE

Clinical trials for ATYPICAL PARKINSON DISEASE explained in plain language.

Never miss a new study

Get alerted when new ATYPICAL PARKINSON DISEASE trials appear

Sign up with your email to follow new studies for ATYPICAL PARKINSON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Magic mushroom therapy targets depression in debilitating diseases

Symptom relief Recruiting now

This study tests whether psilocybin (the active ingredient in magic mushrooms) can safely reduce depression and anxiety in adults with COPD, ALS, multiple sclerosis, or atypical Parkinson disease. 108 participants will receive either two moderate-to-high doses or two very low dos…

Matched conditions: ATYPICAL PARKINSON DISEASE

Phase: PHASE2 • Sponsor: University Medical Center Groningen • Aim: Symptom relief

Last updated May 26, 2026 09:15 UTC

ATYPICAL PARKINSON DISEASE

Get alerted when new ATYPICAL PARKINSON DISEASE trials appear

Magic mushroom therapy targets depression in debilitating diseases